The purpose of this study is to evaluate the long-term safety and efficacy of donidalorsen in people with HAE and the effects of donidalorsen on the number of HAE attacks and their impact on quality of life (QoL).
Hereditary Angioedema
The purpose of this study is to evaluate the long-term safety and efficacy of donidalorsen in people with HAE and the effects of donidalorsen on the number of HAE attacks and their impact on quality of life (QoL).
A Study to Assess the Long-Term Safety and Efficacy of Donidalorsen in the Prophylactic Treatment of Hereditary Angioedema (HAE)
-
Ionis Investigative Site, Paradise Valley, Arizona, United States, 85253
Ionis Investigative Site, La Jolla, California, United States, 92037
Ionis Investigative Site, Santa Monica, California, United States, 90404
Ionis Investigative Site, Walnut Creek, California, United States, 94598
Ionis Investigative Site, Tampa, Florida, United States, 33613
Ionis Investigative Site, Kansas City, Kansas, United States, 66103
Ionis Investigative Site, Boston, Massachusetts, United States, 02114
Ionis Investigative Site, Ann Arbor, Michigan, United States, 48109
Ionis Investigative Site, Detroit, Michigan, United States, 48202
Ionis Investigative Site, Saint Louis, Missouri, United States, 63141
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
12 Years to
ALL
No
Ionis Pharmaceuticals, Inc.,
2027-03